news

July 31 2014
Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting

July 30 2014
BioLineRx to Report Second Quarter 2014 Results on August 6, 2014

July 29 2014
Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement

 

events

 

spotlight